Glycemia in acute coronary syndromes

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Syndrome

Background:

• Diabetes mellitus is a significant risk factor for poor prognosis following acute coronary syndrome (ACS).
• Abnormal glucose metabolism is prevalent in ACS patients, even those without a prior diabetes diagnosis.
• Elevated blood glucose levels at hospital admission correlate with adverse outcomes, including mortality and heart failure.

Purpose of the Study:

• To investigate the prognostic value of abnormal glucose metabolism in patients with acute coronary syndrome.
• To evaluate the utility of admission glycemia, fasting glycemia, and oral glucose tolerance tests in predicting patient outcomes.
• To explore the mechanisms linking hyperglycemia to cardiovascular complications.

Main Methods:

• Analysis of patient data including admission glucose levels (fasting and non-fasting).
• Assessment of fasting glycemia and oral glucose tolerance tests during hospitalization.
• Correlation of glycemic parameters with short-term and long-term clinical outcomes, including mortality and heart failure development.

Main Results:

• Abnormal glycemia regulation is more common than normal regulation in ACS patients.
• High admission blood glucose levels are associated with increased mortality and severe heart failure post-ACS.
• Fasting glycemia is a stronger predictor of short-term outcomes after myocardial infarction than admission glycemia.

Conclusions:

• Glycemic status is a critical prognostic indicator in acute coronary syndrome, impacting both short and long-term outcomes.
• Admission glycemia measurement is crucial for immediate therapeutic strategies.
• Fasting glycemia and oral glucose tolerance tests provide valuable diagnostic information and tools for secondary cardiovascular prevention.